Why the study?
Is propafenone effective and safe for the suppression of spontaneously occurring ventricular arrhythmia?
Is propafenone effective and safe for the suppression of spontaneously occurring ventricular arrhythmia?
Propafenone is an effective antiarrhythmic for ventricular arrhythmias but requires cautious use in patients with severe underlying heart disease due to risks of arrhythmia aggravation and CHF exacerbation.
Answers are grounded in this paper and cite their sources.
Requires caution with propafenone in severe heart disease; leaves open need for randomized trials on ventricular arrhythmia suppression.
Propafenone is a newv IC antiarrhythmic agent that is effective for suppression of spontaneously occurring ventricular arrhythmia as evauated with monitoring and exercise testing. The incidence of nonserious, but disturbing side effects is low and the drug infrequently is discontinued because of adverse reactions. Serious side effects are primarily cardiac and include arrhythmia aggravation, CHF exacerbation, and conduction abnormalities. These complications occur primarily in those with severe underlying heart disease in whom this drug, like other antiarrhythmic agents, must be used cautiously. If the drug is effective and well tolerated, arrhythmia recurrence can be prevented.
No takes yet. Share an insight, caveat, or question.
CUENI et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: